Synthesis of novel 2-phenyl-3-[2-(substituted amino) ethylamino] quinazolin-4(3H)-ones as a new class of H1-antihistaminic agents

[1]  V. Solomon,et al.  Synthesis and pharmacological investigation of novel 4-benzyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H1-antihistaminic agents. , 2007, Bioorganic & medicinal chemistry.

[2]  V. Alagarsamy.  Synthesis and pharmacological investigation of some novel 2-methyl-3-(substituted methylamino)-(3H)-quinazolin-4-ones as histamine H1-receptor blockers. , 2004, Die Pharmazie.

[3]  S. Vijayakumar,et al.  Synthesis and pharmacological investigation of some novel 2-phenyl-3-(substituted methyl amino) quinazolin-4(3H)-ones as H1-receptor blockers. , 2002, Die Pharmazie.

[4]  Y. Ohizumi,et al.  Pharmacological properties of α-mangostin, a novel histamine H1 receptor antagonist , 1996 .

[5]  F. Simons,et al.  The pharmacology and use of H1-receptor-antagonist drugs. , 1994, The New England journal of medicine.

[6]  F. Simons,et al.  H1-Receptor Antagonists , 1994, Drug safety.

[7]  R. Townley,et al.  The effect of age on methacholine response. , 1985, The Journal of allergy and clinical immunology.

[8]  A. Carr,et al.  Synthesis of terfenadine. , 1983, Arzneimittel-Forschung.

[9]  E. F. Van Maanen,et al.  Central nervous system effects of thalidomide. , 1961, The Journal of pharmacology and experimental therapeutics.

[10]  C. G. van Arman,et al.  SC-10049: a catecholamine bronchodilator and hyperglycemic agent. , 1961, The Journal of pharmacology and experimental therapeutics.

[11]  P B DEWS,et al.  The measurement of the influence of drugs on voluntary activity in mice. , 1953, British journal of pharmacology and chemotherapy.

[12]  Y. Ohizumi,et al.  Pharmacological properties of alpha-mangostin, a novel histamine H1 receptor antagonist. , 1996, European journal of pharmacology.